Company News, Financial News

Galderma: Net Sales Top $4 Billion in FY 2023

Dermatological skincare flagship brands, Cetaphil and Alastin, drove substantial growth ahead of the market.

Author Image

By: Lianna Albrizio

Associate Editor

Happi International Top 30 Company Galderma achieved net sales of $4.082 billion in 2023—a record-high for the company, officials said.   Officials said this represents an 8.5% year-on-year increase on a constant currency basis in FY 2023, at the higher end of its 6-9% net sales growth 2023 FY guidance.   Positive momentum across all product categories outperformed fast-growing market segments, with year-on-year net sales growth on a constant currency basis of 12.1% in dermatolog...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters